Centro Nacional de Gripe, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
J Clin Virol. 2011 Jul;51(3):205-8. doi: 10.1016/j.jcv.2011.04.008. Epub 2011 May 17.
Pandemic influenza A (H1N1) 2009 virus appeared in Spain on April 25, 2009 for the first time. This new virus was adamantane-resistant but it was sensitive to neuraminidase (NA) inhibitors oseltamivir and zanamivir.
To detect oseltamivir-resistant pandemic influenza A (H1N1) 2009 viruses by the Spanish Influenza Surveillance System (SISS) and a possible spread of oseltamivir-resistant viruses in Spain since starting of the pandemic situation.
A total of 1229 respiratory samples taken from 413 severe and 766 non-severe patients with confirmed viral detection of pandemic influenza A (H1N1) 2009 viruses from different Spanish regions were analyzed for the specific detection of the H275Y mutation in NA between April 2009 and May 2010.
H275Y NA substitution was found in 8 patients infected with pandemic influenza A (H1N1) 2009 viruses collected in November and December 2009 and in January 2010. All oseltamivir-resistant viruses were detected in severe patients (8/413, 1.93%) who previously received treatment with oseltamivir. Six of these patients were immunocompromised.
In Spain, the number of oseltamivir-resistant pandemic influenza A (H1N1) 2009 viruses is until now very low. No evidence for any spread of oseltamivir-resistant H1N1 viruses is achieved in our Country.
甲型 H1N1 流感病毒于 2009 年 4 月 25 日在西班牙首次出现。这种新型病毒对金刚烷胺具有耐药性,但对神经氨酸酶(NA)抑制剂奥司他韦和扎那米韦敏感。
通过西班牙流感监测系统(SISS)检测奥司他韦耐药的甲型 H1N1 流感 2009 病毒,并在大流行开始后检测西班牙可能出现的奥司他韦耐药病毒传播情况。
共分析了来自西班牙不同地区的 413 例重症和 766 例非重症确诊为甲型 H1N1 流感 2009 病毒感染的患者的 1229 份呼吸道样本,以检测 2009 年 4 月至 2010 年 5 月期间 NA 中的 H275Y 突变的特异性。
在 2009 年 11 月和 12 月以及 2010 年 1 月收集的感染甲型 H1N1 流感 2009 病毒的 8 例患者中发现了 NA 中的 H275Y 取代。所有奥司他韦耐药病毒均在接受奥司他韦治疗的 413 例重症患者(8/413,1.93%)中检测到。其中 6 例患者免疫功能低下。
在西班牙,奥司他韦耐药的甲型 H1N1 流感 2009 病毒数量至今仍然很低。在我国尚未发现奥司他韦耐药的 H1N1 病毒传播的证据。